0001797915-26-000002.txt : 20260915 0001797915-26-000002.hdr.sgml : 20260915 20260915124902 ACCESSION NUMBER: 0001797915-26-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260915 DATE AS OF CHANGE: 20260915 EFFECTIVENESS DATE: 20260915 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Hexamer Therapeutics, Inc CENTRAL INDEX KEY: 0001797915 ORGANIZATION NAME: EIN: 843246637 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-597517 FILM NUMBER: 261380025 BUSINESS ADDRESS: STREET 1: 2345 NE HOPKINS CT CITY: PULLMAN STATE: WA ZIP: 99163 BUSINESS PHONE: 509-715-9251 MAIL ADDRESS: STREET 1: 2345 NE HOPKINS CT CITY: PULLMAN STATE: WA ZIP: 99163 D 1 primary_doc.xml X0708 D LIVE 0001797915 Hexamer Therapeutics, Inc 2345 NE HOPKINS CT PULLMAN WA WASHINGTON 99163 509-715-9251 DELAWARE None None Corporation true Robert H Bogden 2345 NE Hopkins Ct Ste B Pullman WA WASHINGTON 99163 Executive Officer Director Colin Collins 1707 West 7th Ave Vancouver A1 BRITISH COLUMBIA, CANADA V6J5E9 Director Keith Miller 807 Maybelle St Moscow ID IDAHO 83843 Director R. Scott Blackley 43414 Turnberry Isle Ct Leesburg VT VERMONT 20176 Director Stephen Crawford 28 Avon Road Bronxville NY NEW YORK 10708 Director Brad Call 2345 NE Hopkins Ct Ste B Pullman WA WASHINGTON 99163 Director Biotechnology Decline to Disclose 06b false 2026-07-07 false true true false 0 2500000 500000 2000000 false 2 0 0 0 false Hexamer Therapeutics, Inc Robert H. Bogden Robert H. Bogden President 2026-09-15